Cannabigerol (CBG) is a non-psychoactive cannabinoid found in the cannabis plant. Drug tests primarily screen for tetrahydrocannabinol (THC), the main psychoactive compound in cannabis. The question often arises regarding whether other cannabinoids, such as CBG, will trigger a positive result.
The concern stems from the potential for cross-reactivity or contamination. Full-spectrum CBG products may contain trace amounts of THC, even if within the legal limit (typically 0.3% THC). The cumulative effect of consuming such products could, in theory, lead to detectable THC levels in urine or blood, especially with frequent or high-dose usage. Broad-spectrum or isolate CBG products should, in principle, minimize this risk as they undergo processing to remove THC.